News from us and our partners
Tags
Topics
0 results
Moon Surgical appoints Fred Moll, MD, as Board Chair and raises additional $55.4 million in new funding with leading investors Sofinnova Partners and NVIDIA
PinCell's studies open up new indications for lead candidate
Sustainable performance fibers company Werewool raises $3.7 million led by Material Impact and Sofinnova Partners
Alia Therapeutics appoints Adel Nada as Independent Board Director
Alia Therapeutics names Letizia Goretti as Chief Executive Officer
PinCell announces 2 successful in-vivo studies for breakthrough skin disease therapy
Moon Surgical appoints Anne Renevot as Chief Financial Officer
Amolyt Pharma announces Phase 3 clinical trial of Eneboparatide for the treatment of hypoparathyroidism following positive end of Phase 2 Meeting with FDA
Inspirna appoints Dr. Usman “Oz” Azam, M.D., as new Chief Executive Officer
Syngenta and Biotalys enter into strategic partnership in biologicals innovation to advance solutions for sustainable agriculture
Sofinnova Partners appoints Mary McCarthy as Partner for the firm’s Industrial Biotech Strategy
Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis
Alia Therapeutics secures €4.4 million seed financing extension led by Sofinnova Partners
Maestro Surgical Robotics System by Moon Surgical, Now CE Marked
Catamaran Bio Announces Preclinical Data from Allogeneic CAR-NK Cell Therapy Pipeline for Solid Tumors to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2023